#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA621158	F	Irreversible inhibition of ATP binding site of EGFR (lack of phosphorylated EGFR) in A431 cells 8 hour after washing cells free of the inhibitor)		17	ALA1132213	cell-based format	Scientific Literature
2.	ALA674019	B	Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting		23	ALA1133162	cell-based format	Scientific Literature
3.	ALA674020	B	Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography		24	ALA1133162	single protein format	Scientific Literature
4.	ALA674021	F	Irreversible inhibition of formation of phosphorylated EGFR enzyme in A431 cells 8 hr after washing cells free of the inhibitor		23	ALA1133162	cell-based format	Scientific Literature
5.	ALA673949	B	Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.	Homo sapiens	12	ALA1132213	cell-based format	Scientific Literature
6.	ALA673951	B	Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells		14	ALA1133162	cell-based format	Scientific Literature
7.	ALA679551	B	Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells	Homo sapiens	6	ALA1132213	cell-based format	Scientific Literature
8.	ALA856168	B	Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR)		6	ALA1132213	single protein format	Scientific Literature
9.	ALA726618	F	In vivo activity against A431 xenograft in nude mice, net reduction in tumor burden at 75 mg/kg ip dose		1	ALA1132213	organism-based format	Scientific Literature
10.	ALA726269	F	In vivo activity against H125 xenograft in nude mice, net reduction in tumor burden at 200 mg/kg dose		3	ALA1132213	organism-based format	Scientific Literature
11.	ALA726272	F	In vivo activity against H125 xenograft in nude mice, net reduction in tumor burden at 250 mg/kg peroral dose		1	ALA1132213	organism-based format	Scientific Literature
12.	ALA726273	F	In vivo activity against H125 xenograft in nude mice, net reduction in tumor burden at 50 mg/kg ip dose		1	ALA1132213	organism-based format	Scientific Literature
13.	ALA724290	F	In vivo activity against H125 xenograft in nude mice, ratio of treated/control median tumor mass at 260 mg/kg peroral dose		1	ALA1132213	organism-based format	Scientific Literature
14.	ALA724291	F	In vivo activity against H125 xenograft in nude mice, ratio of treated/control median tumor mass at 250 mg/kg peroral dose		1	ALA1132213	organism-based format	Scientific Literature
15.	ALA724292	F	In vivo activity against H125 xenograft in nude mice, ratio of treated/control median tumor mass at 50 mg/kg ip dose		1	ALA1132213	organism-based format	Scientific Literature
16.	ALA723391	F	Difference in days for treated (T) and control (C) A431 cell tumors to reach 750 mg at 75 mg/kg ip dose		1	ALA1132213	organism-based format	Scientific Literature
17.	ALA723392	F	Difference in days for treated (T) and control (C) tumors to reach 750 mg at 250 mg/kg peroral dose		1	ALA1132213	organism-based format	Scientific Literature
18.	ALA727315	F	Difference in days for treated (T) and control (C) A431 cell tumors to reach 750 mg at 260 mg/kg peroral dose		1	ALA1132213	organism-based format	Scientific Literature
19.	ALA727892	F	Difference in days for treated (T) and control (C) H125 cell tumors to reach 750 mg at 50 mg/kg ip dose		1	ALA1132213	organism-based format	Scientific Literature
20.	ALA730266	F	In vivo activity against A431 cell tumor xenograft in nude mice at 75 ip mg/kg dose		1	ALA1132213	organism-based format	Scientific Literature